Cargando…

Mapping research evidence on quality of life in children with atopic dermatitis in sub-Saharan Africa: a scoping review protocol

BACKGROUND: Atopic dermatitis (AD) is a chronic, debilitating disease affecting children worldwide. Several studies have shown the disease to be a significant problem which leads to a diminished quality of life (QoL) for the affected children, but systematic evaluation of such studies in Africa is y...

Descripción completa

Detalles Bibliográficos
Autores principales: Kelbore, Abraham Getachew, Enbiale, Wendemagegn, Mosam, Anisa, van Wyk, Jacqueline M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685884/
https://www.ncbi.nlm.nih.gov/pubmed/36424634
http://dx.doi.org/10.1186/s13643-022-02133-w
_version_ 1784835619097149440
author Kelbore, Abraham Getachew
Enbiale, Wendemagegn
Mosam, Anisa
van Wyk, Jacqueline M.
author_facet Kelbore, Abraham Getachew
Enbiale, Wendemagegn
Mosam, Anisa
van Wyk, Jacqueline M.
author_sort Kelbore, Abraham Getachew
collection PubMed
description BACKGROUND: Atopic dermatitis (AD) is a chronic, debilitating disease affecting children worldwide. Several studies have shown the disease to be a significant problem which leads to a diminished quality of life (QoL) for the affected children, but systematic evaluation of such studies in Africa is yet to be reported. Therefore, this scoping review aims to map research evidence on children with AD and their QoL in sub-Saharan Africa (SSA). METHODS: The scoping review will follow the Arksey and O’Mally methodological framework. The electronic databases to be searched will include PubMed, EBSCOhost (Academic Search Complete, CINAHL, PsycINFO, and Health Sources), and Scopus and Google Scholar, for published literature between 2010 and 2021. The search strategy for the databases will include keywords, Medical Subject Headings terms, and Boolean operators. The reference list of the included sources of evidence and the WHO website will also be consulted for evidence relating to QoL of children with AD in SSA. Two independent reviewers will undertake abstract and full-text article screening with the guidance of eligibility criteria. This review will include studies conducted in SSA, and publications focusing on QoL and associated factors of AD in children. Data will be extracted from the included studies and analyzed qualitatively; NVIVO software V.11 will be used, and the emerging themes reported narratively. The mixed-method appraisal tool (MMAT) will be employed for quality appraisal of included studies. DISCUSSION: We look forward to the findings of several studies that describe the QoL and associated factors among children with AD and that report on the use of different diagnostic criteria, severity scaling and QoL measuring scale tools used to ascertain the presence of AD, scale the severity of AD, and the impact of AD on QoL among children. This will help to improve clinical practice and the QoL of children with AD in SSA. The study findings will be disseminated through publication in a peer-reviewed journal, peer presentations, and presentations at relevant conferences. CONCLUSION: This study will add new knowledge on the QoL in children with AD in the SSA context. The study has the potential to inform research and clinical practice to impact the QoL of children with AD in SSA.
format Online
Article
Text
id pubmed-9685884
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-96858842022-11-25 Mapping research evidence on quality of life in children with atopic dermatitis in sub-Saharan Africa: a scoping review protocol Kelbore, Abraham Getachew Enbiale, Wendemagegn Mosam, Anisa van Wyk, Jacqueline M. Syst Rev Protocol BACKGROUND: Atopic dermatitis (AD) is a chronic, debilitating disease affecting children worldwide. Several studies have shown the disease to be a significant problem which leads to a diminished quality of life (QoL) for the affected children, but systematic evaluation of such studies in Africa is yet to be reported. Therefore, this scoping review aims to map research evidence on children with AD and their QoL in sub-Saharan Africa (SSA). METHODS: The scoping review will follow the Arksey and O’Mally methodological framework. The electronic databases to be searched will include PubMed, EBSCOhost (Academic Search Complete, CINAHL, PsycINFO, and Health Sources), and Scopus and Google Scholar, for published literature between 2010 and 2021. The search strategy for the databases will include keywords, Medical Subject Headings terms, and Boolean operators. The reference list of the included sources of evidence and the WHO website will also be consulted for evidence relating to QoL of children with AD in SSA. Two independent reviewers will undertake abstract and full-text article screening with the guidance of eligibility criteria. This review will include studies conducted in SSA, and publications focusing on QoL and associated factors of AD in children. Data will be extracted from the included studies and analyzed qualitatively; NVIVO software V.11 will be used, and the emerging themes reported narratively. The mixed-method appraisal tool (MMAT) will be employed for quality appraisal of included studies. DISCUSSION: We look forward to the findings of several studies that describe the QoL and associated factors among children with AD and that report on the use of different diagnostic criteria, severity scaling and QoL measuring scale tools used to ascertain the presence of AD, scale the severity of AD, and the impact of AD on QoL among children. This will help to improve clinical practice and the QoL of children with AD in SSA. The study findings will be disseminated through publication in a peer-reviewed journal, peer presentations, and presentations at relevant conferences. CONCLUSION: This study will add new knowledge on the QoL in children with AD in the SSA context. The study has the potential to inform research and clinical practice to impact the QoL of children with AD in SSA. BioMed Central 2022-11-23 /pmc/articles/PMC9685884/ /pubmed/36424634 http://dx.doi.org/10.1186/s13643-022-02133-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Protocol
Kelbore, Abraham Getachew
Enbiale, Wendemagegn
Mosam, Anisa
van Wyk, Jacqueline M.
Mapping research evidence on quality of life in children with atopic dermatitis in sub-Saharan Africa: a scoping review protocol
title Mapping research evidence on quality of life in children with atopic dermatitis in sub-Saharan Africa: a scoping review protocol
title_full Mapping research evidence on quality of life in children with atopic dermatitis in sub-Saharan Africa: a scoping review protocol
title_fullStr Mapping research evidence on quality of life in children with atopic dermatitis in sub-Saharan Africa: a scoping review protocol
title_full_unstemmed Mapping research evidence on quality of life in children with atopic dermatitis in sub-Saharan Africa: a scoping review protocol
title_short Mapping research evidence on quality of life in children with atopic dermatitis in sub-Saharan Africa: a scoping review protocol
title_sort mapping research evidence on quality of life in children with atopic dermatitis in sub-saharan africa: a scoping review protocol
topic Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685884/
https://www.ncbi.nlm.nih.gov/pubmed/36424634
http://dx.doi.org/10.1186/s13643-022-02133-w
work_keys_str_mv AT kelboreabrahamgetachew mappingresearchevidenceonqualityoflifeinchildrenwithatopicdermatitisinsubsaharanafricaascopingreviewprotocol
AT enbialewendemagegn mappingresearchevidenceonqualityoflifeinchildrenwithatopicdermatitisinsubsaharanafricaascopingreviewprotocol
AT mosamanisa mappingresearchevidenceonqualityoflifeinchildrenwithatopicdermatitisinsubsaharanafricaascopingreviewprotocol
AT vanwykjacquelinem mappingresearchevidenceonqualityoflifeinchildrenwithatopicdermatitisinsubsaharanafricaascopingreviewprotocol